PI-RADS — What It Means on Your Imaging Report
Quick Answer
PI-RADS (1–5) is a scoring system used on multiparametric prostate MRI — an MRI that combines several different image types — to estimate the probability of a prostate cancer that is likely to grow or cause harm. The number guides whether a biopsy aimed at a specific spot the MRI flagged is recommended.
What Is PI-RADS?
PI-RADS stands for Prostate Imaging Reporting and Data System. It was developed jointly by the American College of Radiology (ACR), the European Society of Urogenital Radiology (ESUR), and the AdMeTech Foundation so that every radiologist describes prostate MRI findings the same way and recommends the same next step. The current version is PI-RADS v2.1.
PI-RADS is used only on multiparametric prostate MRI — an MRI study that combines several different image types of the prostate in one exam, so the radiologist can look at the gland from several angles before scoring it. The score grades a specific lesion (an area that does not look like normal prostate tissue) on a 1-to-5 scale.
The number itself is not a final diagnosis. It is a structured way to say how likely that specific lesion is to be a clinically significant prostate cancer. That means a cancer likely to grow or cause harm — not a slow-growing finding that might never need treatment. PI-RADS grades the suspicion seen on imaging; it does not confirm or rule out cancer on its own.
Categories / Classification
| PI-RADS Category | Assessment | What It Means / Recommended Action |
|---|---|---|
| 1 | Very low | Clinically significant cancer (a cancer likely to grow or cause harm) is highly unlikely. No biopsy is recommended based on this MRI. Routine follow-up continues based on PSA — the blood test used to screen for prostate cancer — and your urology doctor's plan |
| 2 | Low | Clinically significant cancer is unlikely. No biopsy is recommended based on this MRI alone. Continue routine follow-up with your urology doctor |
| 3 | Intermediate (equivocal) | Equivocal — neither clearly suspicious nor clearly benign. Whether to biopsy depends on PSA density (the PSA level adjusted for prostate size) and your overall risk; biopsy is not automatic |
| 4 | High | A targeted biopsy — aimed at the spot the MRI flagged — is usually recommended, often as a fusion biopsy that overlays the MRI image onto live ultrasound |
| 5 | Very high | Clinically significant cancer is highly likely. An MRI-targeted biopsy (often a fusion biopsy that combines the MRI image with live ultrasound guidance) is typically recommended, and your urology doctor may also begin planning next steps in parallel |
When You Might See This on Your Report
You will only see PI-RADS on one type of scan:
- Multiparametric prostate MRI — an MRI of the prostate that combines several image types in one exam, usually ordered because of a raised PSA blood test, an abnormal prostate examination, or follow-up of a prior finding
- The PI-RADS category usually appears in the Impression section of the report, next to the description of the prostate lesion
PI-RADS is not used on prostate ultrasound, CT, bone scans, or any non-prostate MRI. If your report mentions the prostate but does not include a PI-RADS number, the radiologist may simply not have applied this system — ask the doctor who ordered the scan whether a PI-RADS reading is needed.
Should I Be Worried?
It depends on the category, and the most common misunderstandings are about PI-RADS 3 and PI-RADS 4.
- PI-RADS 1 and 2 are reassuring — the MRI shows nothing suspicious enough to warrant a biopsy based on this scan alone.
- PI-RADS 3 is equivocal, not malignant. It does not mean cancer. It means the imaging features fall in a middle zone where biopsy is not automatic. Whether to biopsy is usually decided by combining the MRI with PSA density (the PSA level adjusted for prostate size) and your overall risk picture. Many PI-RADS 3 lesions stay stable on follow-up.
- PI-RADS 4 has a meaningful chance of being benign. The score grades suspicion, not certainty — a 4 means the radiologist thinks a significant cancer is likely, but a noticeable share of PI-RADS 4 lesions turn out to be benign or non-significant on biopsy. This is honest information about how the score works, not a reason to delay the biopsy your doctor recommends.
- PI-RADS 5 carries the highest level of suspicion on imaging. Biopsy is still done to confirm what the lesion actually is and to grade it, because treatment planning depends on the biopsy result, not the MRI score alone.
In all cases, PI-RADS grades the imaging, not your biology. The final picture comes from the combination of the MRI, your PSA, the examination, and — when needed — the biopsy.
What Should I Do Next?
- Find the PI-RADS number in the Impression section of your report (for example, "PI-RADS 3" or "PI-RADS 4") and write it down exactly as it is written.
- Talk to the doctor who ordered the MRI — usually a urologist, a doctor who specialises in urinary and male reproductive system conditions. Ask them to walk you through the specific PI-RADS number for your case.
- Ask whether a biopsy is recommended, and if so, what type. For PI-RADS 4 and 5, an MRI-targeted biopsy (often a fusion biopsy that overlays the MRI image onto live ultrasound) is the usual next step. For PI-RADS 3, ask whether biopsy, repeat MRI, or watchful follow-up fits your situation best.
- Ask about PSA density and any other risk factors the doctor is weighing — especially for a PI-RADS 3 result, where this often tips the decision one way or the other.
- Do not assume PI-RADS = cancer diagnosis. Even PI-RADS 4 and 5 require a biopsy to confirm cancer and determine how aggressive it is. The PI-RADS number is a guide to the next step, not the answer itself.